摘要
目的探讨超选择性介入治疗对改善中晚期肝癌患者生存质量的临床疗效。方法 70例患者随机分为两组,治疗组35例与对照组35例均采用相同的保肝和化疗方案,治疗组35例采用超选择性插管介入治疗,对照组采用选择性介入治疗,并对两组患者进行生活质量评分和并发症的发生情况。结果对照组治疗后的副反应明显增多,食欲减退者60%,恶心呕吐者占34%,发热者占69%,肝区疼痛占80%,腹胀者占74%,而治疗组治疗后副反应发生例数和对照组相比则显著减少。两组患者治疗后生活质量评分显著高于治疗前,差异有统计学意义(P<0.05);治疗组治疗后生活质量评分虽然高于对照组,但无显著差异。结论超选择性介入治疗可有效提高中晚期肝癌患者生活质量,显著减少副反应的发生率。
Objective To investigate the superselective interventional embolization treatment to improve the quality of life in patients with later hepatocarcinoma.Methods Seventy cases were randomly divided into two groups,One was treatment group（n=35）,and the other was control group（n=35）.The two groups were treated by the same western medicine therapy,and we used superselective interventional embolization for patients in treatment group,only selective interventional embolization were used for patients in control group.And the quality of life and side effects were observed after interventional treatment.Results The treatment group had less side effects after interventional embolization treatment than the control group.And the quality of life of both groups were improved significantly after interventional embolization treatment.But the quality of life had no signif icant difference between the treatment group and control group.Conclusion Superselective interventional embolization can improve the quality of life in patients of late hapatocacinoma,and decrease the side effect signif icantly.
出处
《当代医学》
2010年第29期565-566,共2页
Contemporary Medicine
关键词
肝癌
超选择
介入栓塞
Hapatocacinoma
Superselective
Interventional embolization
